MTOR and leukemia: This resistance can be reversed with ferroptosis-mediated inhibition of the AKT/mechanistic target of rapamycin (mTOR) pathway; thus, modulation of the iron homeostasis/ROS/AKT/mTOR pathway may be a potential strategy for the treatment of drug-resistant leukaemia [107].